Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Sees Large Decrease in Short Interest

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,500 shares, a drop of 15.1% from the April 30th total of 15,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Santhera Pharmaceuticals Price Performance

Santhera Pharmaceuticals stock opened at $14.75 on Friday. The company has a 50 day moving average price of $16.85 and a 200-day moving average price of $12.88. Santhera Pharmaceuticals has a fifty-two week low of $14.75 and a fifty-two week high of $17.54.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).